RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Ahn-Gook Pharmaceutical Co Stock

Ahn-Gook Pharmaceutical Co Liabilities 2024

Ahn-Gook Pharmaceutical Co Liabilities

86.51 B KRW

Ticker

001540.KQ

ISIN

KR7001540004

In 2024, Ahn-Gook Pharmaceutical Co's total liabilities amounted to 86.51 B KRW, a 25.17% difference from the 69.11 B KRW total liabilities in the previous year.

Ahn-Gook Pharmaceutical Co Aktienanalyse

What does Ahn-Gook Pharmaceutical Co do?

Ahn-Gook Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Ahn-Gook Pharmaceutical Co's Liabilities

Ahn-Gook Pharmaceutical Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Ahn-Gook Pharmaceutical Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Ahn-Gook Pharmaceutical Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Ahn-Gook Pharmaceutical Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Ahn-Gook Pharmaceutical Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Ahn-Gook Pharmaceutical Co stock

What is the level of liabilities of Ahn-Gook Pharmaceutical Co this year?

Ahn-Gook Pharmaceutical Co has a debt balance of 86.51 B KRW this year.

What were the liabilities of Ahn-Gook Pharmaceutical Co compared to the previous year?

The liabilities of Ahn-Gook Pharmaceutical Co have increased by 25.17% increased compared to the previous year.

What are the consequences of high debt for investors of Ahn-Gook Pharmaceutical Co?

High liabilities can pose a risk for investors of Ahn-Gook Pharmaceutical Co, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Ahn-Gook Pharmaceutical Co?

Low liabilities mean that Ahn-Gook Pharmaceutical Co has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Ahn-Gook Pharmaceutical Co affect the company?

An increase in liabilities of Ahn-Gook Pharmaceutical Co can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Ahn-Gook Pharmaceutical Co affect the company?

A decrease in the liabilities of Ahn-Gook Pharmaceutical Co can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Ahn-Gook Pharmaceutical Co?

Some factors that can influence the liabilities of Ahn-Gook Pharmaceutical Co include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Ahn-Gook Pharmaceutical Co so important for investors?

The liabilities of Ahn-Gook Pharmaceutical Co are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Ahn-Gook Pharmaceutical Co take to modify the liabilities?

To change its liabilities, Ahn-Gook Pharmaceutical Co can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Ahn-Gook Pharmaceutical Co pay?

Over the past 12 months, Ahn-Gook Pharmaceutical Co paid a dividend of 220 KRW . This corresponds to a dividend yield of about 3.24 %. For the coming 12 months, Ahn-Gook Pharmaceutical Co is expected to pay a dividend of 220 KRW.

What is the dividend yield of Ahn-Gook Pharmaceutical Co?

The current dividend yield of Ahn-Gook Pharmaceutical Co is 3.24 %.

When does Ahn-Gook Pharmaceutical Co pay dividends?

Ahn-Gook Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of January, January, January, January.

How secure is the dividend of Ahn-Gook Pharmaceutical Co?

Ahn-Gook Pharmaceutical Co paid dividends every year for the past 20 years.

What is the dividend of Ahn-Gook Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 220 KRW are expected. This corresponds to a dividend yield of 3.24 %.

In which sector is Ahn-Gook Pharmaceutical Co located?

Ahn-Gook Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Ahn-Gook Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ahn-Gook Pharmaceutical Co from 5/1/2024 amounting to 220 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2023.

When did Ahn-Gook Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 5/1/2024.

What was the dividend of Ahn-Gook Pharmaceutical Co in the year 2023?

In the year 2023, Ahn-Gook Pharmaceutical Co distributed 220 KRW as dividends.

In which currency does Ahn-Gook Pharmaceutical Co pay out the dividend?

The dividends of Ahn-Gook Pharmaceutical Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Ahn-Gook Pharmaceutical Co

Our stock analysis for Ahn-Gook Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ahn-Gook Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.